Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply. Ytterberg SR, Bhatt DL, Connell CA. N Engl J Med 2022;386:1768.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ytterberg SR, Bhatt DL, Connell CA. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply. N Engl J Med 2022;386:1768.
PMID: 35507493